The p53 gene, known for its tumor-suppressive properties, modulates the phosphorylation of the RB protein by influencing cyclin-dependent kinases (CDKs), thereby regulating the E2F family of transcription factors, which are integral to the progression of the cell cycle. The gene discussed is TP53; the disease is neoplasm.